Carboxy Therapy Market to Witness Comprehensive Growth by 2027
Carboxy Therapy Market Introduction
The cutaneous as well as subcutaneous administration of carbon dioxide gas for therapeutic purposes is referred to as carboxy therapy. Originally, this therapy was innovated at the Royal Spas of France in the year 1932 for treatment of patients affected by peripheral arterial occlusive disease. In regions such as South America and Europe, carbon dioxide therapy is being applied for the treatment of stretch marks, cellulite, and hypertrophic scars and the results have been reported to be impressive. Varied number of studies have confirmed that carboxy therapy helps to improve elasticity of skin, improves blood circulation, boosts collagen repair, mends the appearance of fine lines or wrinkles, and abolishes localized fatty deposits.
Read Report Overview: https://www.transparencymarketresearch.com/carboxy-therapy-market.html
Carboxy Therapy Market Competitive Landscape
Merz Pharma GmbH & Co. KGaA
Merz Pharma engages in the development, research, and sale of innovative medical drugs and products for neurological and clinical dermatological purposes. The company operates in the market through its aesthetics and neurotoxins products, which are driving the company towards innovation and strategic acquisitions.
Identify the key factors that will drive your company’s growth, Request a brochure of this report here
Fosun Pharmaceutical Co., Ltd.
The company operates in the medical aesthetic devices business through its subsidiary Alma Lasers Ltd. Fosun Pharma is a business segment of Fosun International Ltd., and a leading health care company in China listed on the SSE and the Hong Kong Stock Exchange. Its subsidiary Alma Lasers is a global developer and provider of laser, light-based, radio-frequency, and ultrasound solutions for the aesthetic and surgical markets.
Allergan plc
Allergan plc engages in the development, manufacture, and marketing of branded pharmaceuticals, devices, and biologic products. The company has presence in over 100 countries, holding top five positions in nearly 20 international markets
Carboxy Therapy Market Dynamics
Growth of Elderly population
The elderly population is one of the major growth drivers for the carboxy therapy market. According to the United Nations, the rate of population ageing in the 21st century is likely to exceed that of the previous century. Between 2015 and 2030, the number of people in the world aged 60 years or above is projected to rise from 901 million to 1.4 billion, an increase by 56%. By 2050, the global elderly population is estimated to more than double its size in 2015, reaching nearly 2.1 billion. This growth of geriatric population continues to lead to a shift toward developing new treatments to reverse the aging process.
Increasing Demand for Minimally Invasive Facial Rejuvenation Treatment
According to the International Society of Aesthetic Plastic Surgery (ISAPS), around 12.1 million non-surgical cosmetic procedures were performed in 2015 worldwide. The increasing demand for non-invasive treatments would propel the market of carboxy therapy during the forecast period.
For simple skin-related problems such as wrinkles, lines, and unwanted hair; patients prefer quicker solutions with minimal pains, which help them resume their duties at the earliest. Patients prefer carboxy therapy, as they involve no side-effects and shorter recovery time.
Expanding operations in future? To get the perfect launch ask for a custom report here
Decrease in Social Taboos Boosting Acceptance of Aesthetics Treatment
Reduction in cultural prohibitions and social taboos is a key factor for increase in the number of aesthetic procedures across the world. Rise in social consciousness about the importance of personal appearance and personality development is another major factor driving the global medical aesthetic devices market.
Carboxy Therapy Market Segmentation
Based on the type, the carboxy therapy market is segmented into
- Table-top
- Portable
- Others
Based on the route of administration, the carboxy therapy market is segmented into
- Subcutaneous
- Epicutaneous
- Others